OR WAIT null SECS
Redwood Shores, CA
Oracle has announced its Oracle Clinical Development Analytics, a component of a larger suite of business intelligence solutions that span clinical development, pre- and post-marketing surveillance and health care, which are designed to provide insights for more informed decision making.
Built on the Oracle Business Intelligence Suite Enterprise Edition Plus, Oracle Clinical Development Analytics is intended to assist life sciences organizations deliver actionable, near real-time insights across the clinical development process, including both active and previously completed trials.
“Life Sciences organizations require systems that can improve the quality and timeliness of their clinical information to enhance the overall effectiveness of their programs,” said Neil de Crescenzo, Senior Vice President and General Manager, Oracle Health Sciences. “Oracle Clinical Development Analytics meets the industry need for a business intelligence application that helps life sciences executives, managers, and team members to make decisions based on current, consistent performance management information that has historically been dispersed across numerous sources and technologies.”
The application can help accelerate study progress and makes it possible for companies to achieve database lock faster. It helps make it easier to identify non-performing sites and enables greater transparency between sponsors and CROs.
With the application’s pre-built clinical warehouse and ad-hoc report builder help end users to build their own reports based on pre-calculated metrics. The centralized warehousing architecture can help to more effectively control IT costs by eliminating the need for multiple, disparate reporting systems.